Artificial Intelligence
Artificial Intelligence
From Manufacturing Scale to Institutional Intelligence
The pharmaceutical industry's competitive edge is evolving from manufacturing capacity to institutional intelligence. Indian Pharma Post explores how HRV Pharma's RIKO uses seven years of proprietary operational data to assess risks, accelerate supplier qualification and support smarter pharmaceutical decision-making.
The Question That Built RIKO
Why do preventable pharmaceutical problems keep recurring years after key decisions are made? Digital Health News explores how HRV Pharma's RIKO uses seven years of operational workflows and ten federated reasoning models to identify risks earlier, accelerate supplier qualification and support faster pharmaceutical decision-making.
One System for Both Sides of Pharma
HRV Pharma's RIKO is designed to bridge the gap between pharmaceutical manufacturers and customers. Drawing on millions of proprietary decisions across 55 countries, the AI-native platform supports faster partner qualification, transparent enquiry matching and early risk assessment across the pharmaceutical value chain.
Catching Risk Before It Becomes a Recall
In the pharmaceutical industry, identifying risks early can help prevent costly quality failures and recalls. PharmaClick explores how HRV Pharma's RIKO platform uses AI-driven pharmaceutical intelligence to assess chemistry risks, nitrosamine potential, supplier reliability and regulatory history before commitments are made.
RIKO by the Numbers
Millennium Newsroom highlights the reported results of RIKO, HRV Pharma's AI-native pharmaceutical operating system. From 94% predictive accuracy in early nitrosamine risk assessments to 85% faster supplier qualification and commercial enquiry screening in under two seconds, RIKO applies pharmaceutical decision intelligence to real business challenges.
Meet RIKO, Built From Seven Years of Pharma Decisions
HRV Pharma has launched RIKO, an AI-native pharmaceutical operating system built on more than seven years of industry decisions. Drawing on insights from a network of 50+ FDA and EU GMP certified partners and customers across 55 countries, RIKO brings together AI-driven reasoning to support pharmaceutical sourcing, risk assessment and supplier qualification.